116 related articles for article (PubMed ID: 8611284)
1. Intravenous Albunex during transesophageal echocardiography: quantitative assessment by videodensitometry and integrated backscatter analysis from unprocessed radiofrequency signals.
Angermann CE; Krüger TM; Junge R; Drewello R; Stempfle HU; Spes CH; Theisen K
J Am Soc Echocardiogr; 1995; 8(6):839-53. PubMed ID: 8611284
[TBL] [Abstract][Full Text] [Related]
2. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres.
Sanders WE; Cheirif J; Desir R; Zoghbi WA; Hoyt BD; Schulz PE; Quiñones MA
Am Heart J; 1991 Dec; 122(6):1660-5. PubMed ID: 1957761
[TBL] [Abstract][Full Text] [Related]
3. Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex.
Monaghan MJ; Metcalfe JM; Odunlami S; Waaler A; Jewitt DE
Eur Heart J; 1993 Sep; 14(9):1200-9. PubMed ID: 8223734
[TBL] [Abstract][Full Text] [Related]
4. A feasibility study on quantitating myocardial perfusion with Albunex, an ultrasonic contrast agent.
Wilson B; Shung KK; Hete B; Levene H; Barnhart JL
Ultrasound Med Biol; 1993; 19(3):181-91. PubMed ID: 8511824
[TBL] [Abstract][Full Text] [Related]
5. [Intrapulmonary arterial injection of Albunex for left heart contrast echocardiography].
Fukui O; Lim YJ; Nakatani D; Kawano S; Kodama K; Masuyama T; Asanuma H; Hori M; Mishima M
J Cardiol; 1998 Feb; 31(2):99-107. PubMed ID: 9513037
[TBL] [Abstract][Full Text] [Related]
6. Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles: a transesophageal echocardiography dipyridamole study.
Voci P; Bilotta F; Merialdo P; Agati L
J Am Soc Echocardiogr; 1994; 7(4):337-46. PubMed ID: 7917341
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of myocardial perfusion with second harmonic imaging--using intravenous injection of Albunex and Levovist].
Hasegawa M; Saiki Y; Kayano H; Katagiri T
Nihon Rinsho; 1998 Apr; 56(4):903-8. PubMed ID: 9577606
[TBL] [Abstract][Full Text] [Related]
8. Some considerations on the measurements of mean frequency shift and integrated backscatter following administration of Albunex.
Wang SH; Chang PH; Shung KK; Levene HB
Ultrasound Med Biol; 1996; 22(4):441-51. PubMed ID: 8795171
[TBL] [Abstract][Full Text] [Related]
9. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
[TBL] [Abstract][Full Text] [Related]
10. Contrast echocardiography: influence of ultrasonic machine settings, mixing conditions, and pressurization on pixel intensity and microsphere size of Albunex solutions in vitro.
Ota T; Hillman ND; Craig D; Kisslo J; Smith PK
J Am Soc Echocardiogr; 1997; 10(1):31-40. PubMed ID: 9046491
[TBL] [Abstract][Full Text] [Related]
11. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization.
Yvorchuk KJ; Sochowski RA; Chan KL
J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629
[TBL] [Abstract][Full Text] [Related]
12. Intravenous albunex during dobutamine stress echocardiography: enhanced localization of left ventricular endocardial borders.
Falcone RA; Marcovitz PA; Perez JE; Dittrich HC; Hopkins WE; Armstrong WF
Am Heart J; 1995 Aug; 130(2):254-8. PubMed ID: 7631604
[TBL] [Abstract][Full Text] [Related]
13. Increasing the dose and rate of Albunex infusion leads to superior left ventricular contrast effect.
Dolan MS; Dent J; deFilippi C; Christopher T; Wible JH; Labovitz AJ
J Am Soc Echocardiogr; 1998 May; 11(5):426-32. PubMed ID: 9619613
[TBL] [Abstract][Full Text] [Related]
14. On the effect of lung filtering and cardiac pressure on the standard properties of ultrasound contrast agent.
Bouakaz A; de Jong N; Cachard C; Jouini K
Ultrasonics; 1998 Feb; 36(1-5):703-8. PubMed ID: 9651600
[TBL] [Abstract][Full Text] [Related]
15. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex.
Gandhok NK; Block R; Ostoic T; Rawal M; Hickle P; Devries S; Feinstein SB
J Am Soc Echocardiogr; 1997; 10(1):25-30. PubMed ID: 9046490
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular opacification by intravenous contrast echocardiography.
Castini D; Gentile F; Ornaghi M; Mangiarotti E; Garbin M; Ravaglia R; Gioventù M; Mantero A; Corno R; Limido A; Morandi F; Fiorentini C; Pezzano A; Repetto S; Haider T; Morris H; Marelli C
G Ital Cardiol; 1999 Jun; 29(6):620-9. PubMed ID: 10396665
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of left atrial appendage stasis in patients with atrial fibrillation using transesophageal echocardiography with an intravenous albumin-contrast agent.
Kato H; Nakanishi M; Maekawa N; Ohnishi T; Yamamoto M
Am J Cardiol; 1996 Aug; 78(3):365-9. PubMed ID: 8759824
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of left ventricular cavity opacification by harmonic imaging after venous injection of Albunex.
Lindner JR; Dent JM; Moos SP; Jayaweera AR; Kaul S
Am J Cardiol; 1997 Jun; 79(12):1657-62. PubMed ID: 9202358
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
[TBL] [Abstract][Full Text] [Related]
20. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial.
Crouse LJ; Cheirif J; Hanly DE; Kisslo JA; Labovitz AJ; Raichlen JS; Schutz RW; Shah PM; Smith MD
J Am Coll Cardiol; 1993 Nov; 22(5):1494-500. PubMed ID: 8227810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
